Latest News and Press Releases

ZyVersa engages CRO, George Clinical, to manage its P2a clinical trial with VAR 200 in Diabetic Kidney Disease expected to begin Q1-2024.

SYDNEY, Dec. 09, 2022 (GLOBE NEWSWIRE) -- George Clinical announces that it has entered into a sale agreement with Hillhouse, a global investment firm with deep experience in partnering with and...

OVERLAND PARK, Ks., Oct. 25, 2022 (GLOBE NEWSWIRE) -- George Clinical, in close collaboration with The George Institute for Global Health, has recently announced the recruitment of more than 5,000...

BEIJING, Sept. 08, 2022 (GLOBE NEWSWIRE) -- George Clinical, a global clinical research organization with an extensive presence throughout the Asia-Pacific region, continues to expand the...

OVERLAND PARK, KS., March 01, 2022 (GLOBE NEWSWIRE) -- George Clinical announces the expansion of its renal scientific leadership into Latin America with the addition of subject matter expert Hernán...

SYDNEY, Feb. 03, 2022 (GLOBE NEWSWIRE) -- George Clinical announces that the organization has been accredited by the Australian Office of the Gene Technology Regulator (OGTR) which allows it to be a...

OVERLAND PARK, KS., Nov. 12, 2021 (GLOBE NEWSWIRE) -- New kidney and metabolic research involving George Clinical teams and scientific leaders has received global attention during the 2021 American...

SYDNEY, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Graham Birrell, PhD, MBA, a researcher and neuropharmacologist with significant clinical research experience in the EU and Asia-Pacific region has joined...